Clinical Trial Update: Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Bofukang Vaginal Suppository for aerobic vaginitis is currently recruiting at Peking University Shenzhen Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aerobic Vaginitis
• Vaginitis

Drugs mentioned

• Bofukang Vaginal Suppository

Snippet

Sponsor: Peking University Shenzhen Hospital | Conditions: Vaginitis | Phase 3 | Status: RECRUITING